Illumina to present at UBS Global Healthcare Conference on Nov 10, sharing updates on genomic tech progress

Illumina, a leader in DNA sequencing technology, announced its management will participate in the UBS Global Healthcare Conference on November 10, 2026. The event includes a fireside chat webcast available on Illumina's investor website, where the company will discuss its latest innovations and market developments. This presentation is important as it provides investors insight into Illumina's ongoing efforts to advance genomic technologies impacting health and agriculture. A replay of the webcast will be available for 30 days after the event.

Illumina's upcoming participation in the UBS Global Healthcare Conference highlights its role in advancing genomic technology. On Pluang, ILMN trades at USD 268.13 with a 1-day gain of 2.08% as of Oct 21, 2026 03:12 WIB.